ResearcherJiangsu UniversityActive in the last 2 years

Min Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0644-6911; OpenAlex author ID A5100771116. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2024: 2 papers

Papers 2

Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care. Last author DOI 10.3390/biomedicines13010076 ↗
Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer. Last author DOI 10.7150/jca.88397 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenyu Zhang · 1 shared paper, 2024 · strength 0.31
- Paper Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care. DOI 10.3390/biomedicines13010076 ↗
Qi Wang · 1 shared paper, 2024 · strength 0.23
- Paper Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types,… DOI 10.7150/jca.88397 ↗
Yuntao Ding · 1 shared paper, 2024 · strength 0.23
- Paper Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types,… DOI 10.7150/jca.88397 ↗
Huizhi Wang · 1 shared paper, 2024 · strength 0.23
- Paper Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types,… DOI 10.7150/jca.88397 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.